When PCF was founded in 1993, only 3 FDA-approved therapies existed to treat prostate cancer. Today, patients and clinicians have access to 27 FDA-approved prostate cancer treatments, of which 14 received PCF development funding.
$1 Billion
Over $1B raised to fund Cutting-Edge Prostate Cancer Research
2,250
More Than 2,250 Research Projects At 257 Leading Global Cancer Centers
Young Investigators
408 Young Investigators Cultivated and Mentored in Prostate Cancer
14
14 New FDA-Approved Prostate Cancer Therapies Developed with Early-Stage PCF Funding
Multiple Cancers
Treatments for Multiple Other Cancers Cancers Including Breast, Colon,
Alive Today
More Men Alive Today Thanks to Innovations and Treatments Developed by PCF
The Work We Fund
PCF’s Young Investigator (YI) Awards
Our YI program works to increase the number of MD, MD-PhD, and PhD scientists focused on prostate cancer research worldwide who are engaged in ground breaking new discovery work.
PCF’s “Team Science” Challenge Awards
PCF’s Challenge Awards support cross-disciplinary teams of cancer investigators fast-forwarding breakthrough concepts in precision treatment for prostate cancer at every stage of diagnosis.
